The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Counsel to pipeline company in manufacturing specialized products
Represented pipeline company, as lead counsel, in the design, manufacture and procurement of $5 million worth of specialized products. more
State of West Virginia ex rel. E. I. du Pont de Nemours and Company v. Perrine
The firm served as appellate counsel for a trial team representing DuPont in a major medical monitoring class-action in West Virginia and briefed a more
Indemnity and insurance claims for the costs of remediating environmental contamination
The firm served as lead counsel for Raytheon Engineers & Constructors, Inc. in litigation brought by the owner of an experimental solvent refined more
Regulatory work for non-profit mental health providers
Represented over a dozen non-profit mental health providers in opposing North Carolina's decision to cut the rate of Medicaid reimbursement by more